Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan in adults with Marfan syndrome
NL-OMON25140Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of losartan in Marfan syndrome (MFS) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Largest change in absolute aortic diameter. Started Feb 2008; status: recruiting.
02
Drugs
losartan
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on NL-OMON25140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25140.